Sterling Capital Management LLC Century Therapeutics, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 146 shares of IPSC stock, worth $194. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146Holding current value
$194% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IPSC
# of Institutions
64Shares Held
38.1MCall Options Held
7KPut Options Held
300-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$7.2 Million1.66% of portfolio
-
Vr Adviser, LLC New York, NY5.39MShares$7.17 Million0.95% of portfolio
-
Boxer Capital, LLC San Diego, CA3.9MShares$5.19 Million0.35% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$4.27 Million0.43% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$3.85 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $78.3M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...